{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:07:44Z","timestamp":1768255664018,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":757,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (NSFC)","doi-asserted-by":"publisher","award":["81630061"],"award-info":[{"award-number":["81630061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (NSFC)","doi-asserted-by":"publisher","award":["81473255"],"award-info":[{"award-number":["81473255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2017-I2M-1\u2013014"],"award-info":[{"award-number":["2017-I2M-1\u2013014"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1074\/jbc.ra118.003538","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T18:45:17Z","timestamp":1529606717000},"page":"12703-12718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial\u2013approved membrane fusion inhibitor"],"prefix":"10.1016","volume":"293","author":[{"given":"Danwei","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanmian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA118.003538_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1146\/annurev.biochem.70.1.777","article-title":"Mechanisms of viral membrane fusion and its inhibition","volume":"70","author":"Eckert","year":"2001","journal-title":"Annu. Rev. Biochem"},{"key":"10.1074\/jbc.RA118.003538_bib2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/387426a0","article-title":"Atomic structure of the ectodomain from HIV-1 gp41","volume":"387","author":"Weissenhorn","year":"1997","journal-title":"Nature"},{"key":"10.1074\/jbc.RA118.003538_bib3","doi-asserted-by":"crossref","first-page":"12303","DOI":"10.1073\/pnas.94.23.12303","article-title":"Atomic structure of a thermostable subdomain of HIV-1 gp41","volume":"94","author":"Tan","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.003538_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)80205-6","article-title":"Core structure of gp41 from the HIV envelope glycoprotein","volume":"89","author":"Chan","year":"1997","journal-title":"Cell"},{"key":"10.1074\/jbc.RA118.003538_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0092-8674(00)80066-5","article-title":"Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket","volume":"99","author":"Eckert","year":"1999","journal-title":"Cell"},{"key":"10.1074\/jbc.RA118.003538_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0092-8674(00)81430-0","article-title":"HIV entry and its inhibition","volume":"93","author":"Chan","year":"1998","journal-title":"Cell"},{"key":"10.1074\/jbc.RA118.003538_bib7","doi-asserted-by":"crossref","first-page":"15613","DOI":"10.1073\/pnas.95.26.15613","article-title":"Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target","volume":"95","author":"Chan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.003538_bib8","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2174\/1381612811319100004","article-title":"Synthesized peptide inhibitors of HIV-1 gp41-dependent membrane fusion","volume":"19","author":"He","year":"2013","journal-title":"Curr. Pharm. Des"},{"key":"10.1074\/jbc.RA118.003538_bib9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2174\/138161210790963751","article-title":"Peptide-based inhibitors of the HIV envelope protein and other class I viral fusion proteins","volume":"16","author":"Steffen","year":"2010","journal-title":"Curr. Pharm. Des"},{"key":"10.1074\/jbc.RA118.003538_bib10","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.2174\/138161210794079218","article-title":"Inhibition of HIV-1 by fusion inhibitors","volume":"16","author":"Eggink","year":"2010","journal-title":"Curr. Pharm. Des"},{"key":"10.1074\/jbc.RA118.003538_bib11","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa035026","article-title":"Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America","volume":"348","author":"Lalezari","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA118.003538_bib12","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/3293","article-title":"Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry","volume":"4","author":"Kilby","year":"1998","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA118.003538_bib13","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00002030-200409030-00007","article-title":"Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates","volume":"18","author":"Sista","year":"2004","journal-title":"AIDS"},{"key":"10.1074\/jbc.RA118.003538_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jmv.20141","article-title":"Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure","volume":"74","author":"Poveda","year":"2004","journal-title":"J. Med. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkh330","article-title":"Resistance to enfuvirtide, the first HIV fusion inhibitor","volume":"54","author":"Greenberg","year":"2004","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1074\/jbc.RA118.003538_bib16","doi-asserted-by":"crossref","first-page":"12428","DOI":"10.1128\/JVI.78.22.12428-12437.2004","article-title":"Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor","volume":"78","author":"Baldwin","year":"2004","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib17","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.RA118.003538_bib18","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/JVI.72.2.986-993.1998","article-title":"Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides","volume":"72","author":"Rimsky","year":"1998","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib19","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1074\/jbc.M800200200","article-title":"Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor","volume":"283","author":"He","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib20","doi-asserted-by":"crossref","first-page":"12772","DOI":"10.1073\/pnas.0701478104","article-title":"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus","volume":"104","author":"Dwyer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.003538_bib21","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J","article-title":"Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells","volume":"41","author":"Otaka","year":"2002","journal-title":"Angew. Chem. Int. Ed. Engl"},{"key":"10.1074\/jbc.RA118.003538_bib22","doi-asserted-by":"crossref","first-page":"16332","DOI":"10.1073\/pnas.0807335105","article-title":"Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains","volume":"105","author":"He","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.003538_bib23","doi-asserted-by":"crossref","first-page":"e01839","DOI":"10.1128\/JVI.01839-16","article-title":"A helical short-peptide fusion inhibitor with highly potent activity against human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus","volume":"91","author":"Xiong","year":"2017","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/QAD.0000000000000498","article-title":"Design of a highly potent HIV-1 fusion inhibitor targeting the gp41 pocket","volume":"29","author":"Chong","year":"2015","journal-title":"AIDS"},{"key":"10.1074\/jbc.RA118.003538_bib25","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/jac\/dku183","article-title":"The M-T hook structure increases the potency of HIV-1 fusion inhibitor sifuvirtide and overcomes drug resistance","volume":"69","author":"Chong","year":"2014","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1074\/jbc.RA118.003538_bib26","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1074\/jbc.M111.317883","article-title":"Broad antiviral activity and crystal structure of HIV-1 fusion inhibitor sifuvirtide","volume":"287","author":"Yao","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-4690-11-40","article-title":"Two M-T hook residues greatly improve the antiviral activity and resistance profile of the HIV-1 fusion inhibitor SC29EK","volume":"11","author":"Chong","year":"2014","journal-title":"Retrovirology"},{"key":"10.1074\/jbc.RA118.003538_bib28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1096\/fj.12-222547","article-title":"Short-peptide fusion inhibitors with high potency against wild-type and enfuvirtide-resistant HIV-1","volume":"27","author":"Chong","year":"2013","journal-title":"FASEB J"},{"key":"10.1074\/jbc.RA118.003538_bib29","doi-asserted-by":"crossref","first-page":"26618","DOI":"10.1074\/jbc.M112.381079","article-title":"Structural basis of potent and broad HIV-1 fusion inhibitor CP32M","volume":"287","author":"Yao","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib30","doi-asserted-by":"crossref","first-page":"34558","DOI":"10.1074\/jbc.M112.390393","article-title":"The M-T hook structure is critical for design of HIV-1 fusion inhibitors","volume":"287","author":"Chong","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib31","doi-asserted-by":"crossref","first-page":"20281","DOI":"10.1074\/jbc.M112.354126","article-title":"Discovery of critical residues for viral entry and inhibition through structural insight of HIV-1 fusion inhibitor CP621-652","volume":"287","author":"Chong","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib32","doi-asserted-by":"crossref","first-page":"e00288","DOI":"10.1128\/JVI.00288-17","article-title":"A lipopeptide HIV-1\/2 fusion inhibitor with highly potent in vitro, ex vivo, and in vivo antiviral activity","volume":"91","author":"Chong","year":"2017","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib33","doi-asserted-by":"crossref","first-page":"11426","DOI":"10.1128\/JVI.75.23.11426-11436.2001","article-title":"Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication","volume":"75","author":"Johnson","year":"2001","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib34","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.1128\/JVI.01741-15","article-title":"Genetic pathway of HIV-1 resistance to novel fusion inhibitors targeting the Gp41 pocket","volume":"89","author":"Su","year":"2015","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib35","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1128\/JVI.00373-15","article-title":"Mechanism of HIV-1 resistance to short-peptide fusion inhibitors targeting the Gp41 pocket","volume":"89","author":"Su","year":"2015","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib36","doi-asserted-by":"crossref","first-page":"e02044","DOI":"10.1128\/JVI.02044-17","article-title":"Mechanism of HIV-1 resistance to an electronically constrained \u03b1-helical peptide membrane fusion inhibitor","volume":"92","author":"Wu","year":"2018","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib37","doi-asserted-by":"crossref","first-page":"12471","DOI":"10.1021\/bi051092d","article-title":"Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation","volume":"44","author":"Dimitrov","year":"2005","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA118.003538_bib38","doi-asserted-by":"crossref","first-page":"21755","DOI":"10.1074\/jbc.M603135200","article-title":"Characterization of the HIV N-terminal fusion peptide-containing region in context of key gp41 fusion conformations","volume":"281","author":"Sackett","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imbio.2008.04.005","article-title":"Identification of critical antibody-binding sites in the HIV-1 gp41 six-helix bundle core as potential targets for HIV-1 fusion inhibitors","volume":"214","author":"Li","year":"2009","journal-title":"Immunobiology"},{"key":"10.1074\/jbc.RA118.003538_bib40","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.00237-13","article-title":"HIV-1 resistance mechanism to an electrostatically constrained peptide fusion inhibitor that is active against T-20-resistant strains","volume":"57","author":"Shimane","year":"2013","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.RA118.003538_bib41","doi-asserted-by":"crossref","first-page":"12929","DOI":"10.1128\/JVI.05391-11","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib42","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1074\/jbc.M110.199323","article-title":"In vitro selection and characterization of HIV-1 variants with increased resistance to sifuvirtide, a novel HIV-1 fusion inhibitor","volume":"286","author":"Liu","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib43","doi-asserted-by":"crossref","first-page":"10785","DOI":"10.1128\/JVI.05331-11","article-title":"Resistance of human immunodeficiency virus type 1 to a third-generation fusion inhibitor requires multiple mutations in gp41 and is accompanied by a dramatic loss of gp41 function","volume":"85","author":"Eggink","year":"2011","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib44","doi-asserted-by":"crossref","first-page":"39471","DOI":"10.1074\/jbc.M110.145789","article-title":"Resistance profiles of novel electrostatically constrained HIV-1 fusion inhibitors","volume":"285","author":"Shimura","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib45","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1128\/JVI.00352-08","article-title":"Selection of T1249-resistant human immunodeficiency virus type 1 variants","volume":"82","author":"Eggink","year":"2008","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib46","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1128\/JVI.01616-16","article-title":"HIV-1 escape from a peptidic anchor inhibitor through stabilization of the envelope glycoprotein spike","volume":"90","author":"Eggink","year":"2016","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12977-014-0086-8","article-title":"Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics","volume":"11","author":"De Feo","year":"2014","journal-title":"Retrovirology"},{"key":"10.1074\/jbc.RA118.003538_bib48","doi-asserted-by":"crossref","first-page":"26941","DOI":"10.1074\/jbc.M109.004416","article-title":"Detailed mechanistic insights into HIV-1 sensitivity to three generations of fusion inhibitors","volume":"284","author":"Eggink","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib49","doi-asserted-by":"crossref","first-page":"25813","DOI":"10.1074\/jbc.M601457200","article-title":"Kinetic dependence to HIV-1 entry inhibition","volume":"281","author":"Steger","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib50","doi-asserted-by":"crossref","first-page":"16498","DOI":"10.1074\/jbc.M117.791731","article-title":"Complex interplay of kinetic factors governs the synergistic properties of HIV-1 entry inhibitors","volume":"292","author":"Ahn","year":"2017","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib51","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/AAC.01067-08","article-title":"Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev","volume":"53","author":"Svicher","year":"2009","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.RA118.003538_bib52","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/JVI.79.2.764-770.2005","article-title":"Mutations conferring resistance to human immunodeficiency virus type 1 fusion inhibitors are restricted by gp41 and Rev-responsive element functions","volume":"79","author":"Nameki","year":"2005","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib53","doi-asserted-by":"crossref","first-page":"e32599","DOI":"10.1371\/journal.pone.0032599","article-title":"Biophysical property and broad anti-HIV activity of albuvirtide, a 3-maleimimidopropionic acid-modified peptide fusion inhibitor","volume":"7","author":"Chong","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA118.003538_bib54","doi-asserted-by":"crossref","first-page":"14681","DOI":"10.1074\/jbc.M109.067090","article-title":"Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain","volume":"285","author":"Kondo","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.003538_bib55","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/protein\/gzs051","article-title":"Generation of a dual-functional split-reporter protein for monitoring membrane fusion using self-associating split GFP","volume":"25","author":"Ishikawa","year":"2012","journal-title":"Protein Eng. Des. Sel"},{"key":"10.1074\/jbc.RA118.003538_bib56","doi-asserted-by":"crossref","first-page":"10213","DOI":"10.1128\/JVI.72.12.10213-10217.1998","article-title":"A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein","volume":"72","author":"Jiang","year":"1998","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.003538_bib57","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1128\/JVI.00319-08","article-title":"Identification of a critical motif for the human immunodeficiency virus type 1 (HIV-1) gp41 core structure: implications for designing novel anti-HIV fusion inhibitors","volume":"82","author":"He","year":"2008","journal-title":"J. Virol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820313259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820313259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA118.003538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T04:27:47Z","timestamp":1641270467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820313259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":57,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0021925820313259"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra118.003538","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial\u2013approved membrane fusion inhibitor","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA118.003538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Yu et al.","name":"copyright","label":"Copyright"}]}}